There is growing interest in inflammation, adipose tissue, and the atherosclerotic process in vessels. As a result of recent studies, it is known that obesity and increased epicardial adipose tissue are important factors affecting the pathogenesis of atherosclerosis. Adipose tissue releases inflammatory mediators like an endocrine organ. It produces cytokines, such as adiponectin, leptin, resistin, and interleukins, and these mediators cause an increase in inflammatory activation in the arterial wall. Adipose tissue acts as a source of proinflammatory activity, and it is therefore called obesity-related inflammatory activity (1).
